GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Gross Margin %

Kindstar Globalgene Technology (HKSE:09960) Gross Margin % : 49.50% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Kindstar Globalgene Technology's Gross Profit for the six months ended in Jun. 2023 was HK$267 Mil. Kindstar Globalgene Technology's Revenue for the six months ended in Jun. 2023 was HK$539 Mil. Therefore, Kindstar Globalgene Technology's Gross Margin % for the quarter that ended in Jun. 2023 was 49.50%.


The historical rank and industry rank for Kindstar Globalgene Technology's Gross Margin % or its related term are showing as below:

HKSE:09960' s Gross Margin % Range Over the Past 10 Years
Min: 43.49   Med: 52.2   Max: 54.3
Current: 46.64


During the past 6 years, the highest Gross Margin % of Kindstar Globalgene Technology was 54.30%. The lowest was 43.49%. And the median was 52.20%.

HKSE:09960's Gross Margin % is ranked better than
50.46% of 216 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.595 vs HKSE:09960: 46.64

Kindstar Globalgene Technology had a gross margin of 49.50% for the quarter that ended in Jun. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Kindstar Globalgene Technology was 0.00% per year.


Kindstar Globalgene Technology Gross Margin % Historical Data

The historical data trend for Kindstar Globalgene Technology's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Gross Margin % Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 54.30 51.71 52.20 43.49 46.64

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.17 45.29 41.86 49.50 43.67

Competitive Comparison of Kindstar Globalgene Technology's Gross Margin %

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Gross Margin % falls into.



Kindstar Globalgene Technology Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Kindstar Globalgene Technology's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=673.4 / 1548.427
=(Revenue - Cost of Goods Sold) / Revenue
=(1548.427 - 874.987) / 1548.427
=43.49 %

Kindstar Globalgene Technology's Gross Margin for the quarter that ended in Jun. 2023 is calculated as


Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=266.8 / 538.971
=(Revenue - Cost of Goods Sold) / Revenue
=(538.971 - 272.176) / 538.971
=49.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Kindstar Globalgene Technology  (HKSE:09960) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Kindstar Globalgene Technology had a gross margin of 49.50% for the quarter that ended in Jun. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Kindstar Globalgene Technology Gross Margin % Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology (HKSE:09960) Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines